Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection.
Lewis
Roshan
R
Hogan
Holly
H
Howell
Allan
A
Safdar
Amar
A
D000328:Adult; D001682:Biological Availability; D005670:Fusarium; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D016867:Immunocompromised Host; D007371:Interferon-gamma / Q000627:therapeutic use*; D007938:Leukemia / Q000150:complications; D008297:Male; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology; D009503:Neutropenia / Q000150:complications; D011994:Recombinant Proteins; D016879:Salvage Therapy; D016896:Treatment Outcome; D014230:Triazoles / Q000493:pharmacokinetics*
D011994:Recombinant Proteins; D014230:Triazoles; C101425:posaconazole; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor